The Express Tribune CENTER (0.0) Reliability: 7.0/10

International Investment to acquire Novartis Pharma

✍️ Our Correspondent 📅 November 09, 2025 04:30 AM 🕐 Scraped: November 09, 2025

Summary: International Investment to acquire Novartis Pharma

Novartis makes nilotinib, a drug used to treat chronic myeloid leukaemia. PHOTO: AFP

The Competition Commission of Pakistan (CCP) has authorised the acquisition of Novartis Ph

📰

Continue Reading on The Express Tribune

This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.

Read Full Article →

How do you feel about this article?

Read Original Article →

📝 Article Information

Author

Our Correspondent

Original Publisher

🌍 The Express Tribune

CENTER Bias (0.0)

Published Date

November 09, 2025 at 04:30 AM

ℹ️

Disclaimer

ArkforgeAI.com - Newsource is a news aggregation platform. We do not create, write, or produce original news content. All articles are sourced from their respective publishers and remain the property of their original creators. We analyze and aggregate news from multiple sources to provide diverse perspectives across the political spectrum.

The content displayed here is for informational purposes only. For the complete and original article, please visit the source's website using the "Read Original Article" link above.

Desktop Only

International Investment to acquire Novartis Pharma

Continue Reading on The Express Tribune

How do you feel about this article?

📝 Article Information

Author

Original Publisher

Published Date

Disclaimer

More from The Express Tribune